Advertisement
Loading...

Curaleaf Holdings, Inc.

CURLFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$3.59
$0.43(13.61%)
U.S. Market is Open • 14:55
Advertisement

Curaleaf Holdings, Inc. Fundamental Analysis

Curaleaf Holdings, Inc. (CURLF) shows weak financial fundamentals with a PE ratio of -26.66, profit margin of -7.93%, and ROE of -12.61%. The company generates $1.3B in annual revenue with weak year-over-year growth of 0.94%.

Key Strengths

PEG Ratio-0.52
Current Ratio1.56

Areas of Concern

ROE-12.61%
Operating Margin0.85%
Cash Position3.92%
We analyze CURLF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -2.4/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-2.4/100

We analyze CURLF's fundamental strength across five key dimensions:

Efficiency Score

Weak

CURLF struggles to generate sufficient returns from assets.

ROA > 10%
-3.65%

Valuation Score

Excellent

CURLF trades at attractive valuation levels.

PE < 25
-26.66
PEG Ratio < 2
-0.52

Growth Score

Weak

CURLF faces weak or negative growth trends.

Revenue Growth > 5%
0.94%
EPS Growth > 10%
-6.90%

Financial Health Score

Moderate

CURLF shows balanced financial health with some risks.

Debt/Equity < 1
1.27
Current Ratio > 1
1.56

Profitability Score

Weak

CURLF struggles to sustain strong margins.

ROE > 15%
-1260.79%
Net Margin ≥ 15%
-7.93%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is CURLF Expensive or Cheap?

P/E Ratio

CURLF trades at -26.66 times earnings. This suggests potential undervaluation.

-26.66

PEG Ratio

When adjusting for growth, CURLF's PEG of -0.52 indicates potential undervaluation.

-0.52

Price to Book

The market values Curaleaf Holdings, Inc. at 3.33 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

3.33

EV/EBITDA

Enterprise value stands at 9.91 times EBITDA. This is generally considered low.

9.91

How Well Does CURLF Make Money?

Net Profit Margin

For every $100 in sales, Curaleaf Holdings, Inc. keeps $-7.93 as profit after all expenses.

-7.93%

Operating Margin

Core operations generate 0.85 in profit for every $100 in revenue, before interest and taxes.

0.85%

ROE

Management delivers $-12.61 in profit for every $100 of shareholder equity.

-12.61%

ROA

Curaleaf Holdings, Inc. generates $-3.65 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.65%

Following the Money - Real Cash Generation

Operating Cash Flow

Curaleaf Holdings, Inc. generates limited operating cash flow of $121.00M, signaling weaker underlying cash strength.

$121.00M

Free Cash Flow

Curaleaf Holdings, Inc. produces free cash flow of $55.36M, offering steady but limited capital for shareholder returns and expansion.

$55.36M

FCF Per Share

Each share generates $0.07 in free cash annually.

$0.07

FCF Yield

CURLF converts 1.93% of its market value into free cash.

1.93%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-26.66

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.52

vs 25 benchmark

P/B Ratio

Price to book value ratio

3.33

vs 25 benchmark

P/S Ratio

Price to sales ratio

2.16

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

1.27

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.56

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.13

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

0.004

vs 25 benchmark

How CURLF Stacks Against Its Sector Peers

MetricCURLF ValueSector AveragePerformance
P/E Ratio-26.6629.35 Better (Cheaper)
ROE-12.61%705.00% Weak
Net Margin-7.93%-53441.00% (disorted) Weak
Debt/Equity1.270.39 Weak (High Leverage)
Current Ratio1.564.01 Neutral
ROA-3.65%-19815.00% (disorted) Weak

CURLF outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Curaleaf Holdings, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

43.00%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-185.64%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

688.86%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ